Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019;15(6):1215-1227.
doi: 10.1080/21645515.2018.1553593. Epub 2019 Feb 8.

Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?

A D Steele  1 , J C Victor  2 , M E Carey  1 , J E Tate  3 , D E Atherly  2 , C Pecenka  2 , Z Diaz  1 , U D Parashar  3 , C D Kirkwood  1
Affiliations
Review

Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?

A D Steele et al. Hum Vaccin Immunother. 2019.

Abstract

Rotavirus vaccines have been introduced into over 95 countries globally and demonstrate substantial impact in reducing diarrheal mortality and diarrheal hospitalizations in young children. The vaccines are also considered by WHO as "very cost effective" interventions for young children, particularly in countries with high diarrheal disease burden. Yet the full potential impact of rotavirus immunization is yet to be realized. Large countries with big birth cohorts and where disease burden is high in Africa and Asia have not yet implemented rotavirus vaccines at all or at scale. Significant advances have been made demonstrating the impact of the vaccines in low- and lower-middle income countries, yet the modest effectiveness of the vaccines in these settings is challenging. Current research highlights these challenges and considers alternative strategies to overcome them, including alternative immunization schedules and host factors that may inform us of new opportunities.

Keywords: RotaTeq™; RotaVac™; Rotarix™; Rotavirus vaccines; cost-effectiveness; vaccine impact.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Global introduction of rotavirus vaccines. http://view-hub.org/viz/#
See this image and copyright information in PMC

References

    1. You D, Hug L, Ejdemyr S, Idele P, Hogan D, Mathers C, Gerland P, New JR, Alkema L.. 2015. Global, regional, and national levels and trends in under-5 mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN inter-agency group for child mortality estimation. Lancet. 386:2275–2286. doi: 10.1016/S0140-6736(15)00120-8. - DOI - PubMed
    1. Walker CL, Aryee MJ, Boschi-Pinto C, Black RE, Myer L. 2012. Estimating diarrhea mortality among young children in low- and middle-income countries. PLoS ONE. 7:e29151. doi: 10.1371/journal.pone.0029151. - DOI - PMC - PubMed
    1. GBD 2016 Causes of Death Collaborators Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390:1151–1210. doi: 10.1016/S0140-6736(17)32152-9. - DOI - PMC - PubMed
    1. Tate JE, Burton AH, Boschi-Pinto C, Parashar UD. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000-2013. Clin Infect Dis. 2016;62(S2):S96–105. doi: 10.1093/cid/civ1013. - DOI - PMC - PubMed
    1. Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, Armah G, Bines JE, Brewer TG, Colombara DV, et al. The changing epidemiology of rotavirus and its role as the leading cause of diarrhea burden among children under 5 years old. JAMA Pediatr. 2018. August 13. doi: 10.1001/jamapediatrics.2018.1960. - DOI - PMC - PubMed

MeSH terms

Substances